Simplex Trading, LLC Instil Bio, Inc. Transaction History

Simplex Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$0.4 - $0.63 $10,182 - $16,036	-25,455 Reduced 63.04%	14,924 $6,000
Q2 2023 Aug 04, 2023	BUY	$0.51 - $0.67 $19,786 - $25,994	38,798 Added 2454.02%	40,379 $22,000
Q1 2023 Apr 27, 2023	BUY	$0.6 - $0.91 $720 - $1,092	1,200 Added 314.96%	1,581 $1,000
Q4 2022 Feb 02, 2023	SELL	$0.48 - $5.33 $72 - $810	-152 Reduced 28.52%	381 $0
Q3 2022 Nov 04, 2022	BUY	$4.65 - $7.37 $2,478 - $3,928	533 New	533 $2,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $3.23B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.